[Clinical features of multiple myeloma]

Area of Science:

• Hematology
• Oncology
• Internal Medicine

Context:

• The International Myeloma Working Group (IMWG) has introduced a revised classification system for myeloma.
• This new system differentiates between asymptomatic and symptomatic myeloma.
• The classification hinges on the presence or absence of myeloma-related organ or tissue impairment (ROTI).

Purpose:

• To outline the IMWG's new classification criteria for asymptomatic and symptomatic myeloma.
• To emphasize the importance of recognizing myeloma-related organ or tissue impairment (ROTI).
• To highlight the clinical significance of accurate diagnosis for treatment initiation.

Summary:

• Myeloma classification now depends on ROTI, as defined by the IMWG.
• Patients without overt symptoms may be classified as symptomatic if ROTI is present.
• Conversely, patients with symptoms might be classified as asymptomatic if ROTI is not definitively linked to myeloma.

Impact:

• Accurate diagnosis of symptomatic myeloma is critical for prompt and effective treatment.
• Recognizing ROTI facilitates immediate management of symptomatic myeloma.
• Proper management of symptomatic myeloma significantly impacts patient quality of life and survival rates.